MetLife Investment Management’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
MetLife Investment Management's G Position: Q2 2026 in Review
MetLife Investment Management reduced its Genpact (G) stake by 2.7% in Q2 2026, selling an estimated $68.2K and leaving 75,859 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #1131.
MetLife Investment Management first reported a position in G in Q3 2018 and has held it in 23 quarters since. The position peaked at $5.1M in Q4 2022. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.
- MetLife Investment Management held 75,859 shares of Genpact worth $2.09M as of Q2 2026.
- MetLife Investment Management sold 2,075 Genpact shares in Q2 2026, an estimated $68.2K.
- Genpact made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1131 holding.
- MetLife Investment Management first reported a position in Genpact in Q3 2018 and has held it in 23 quarters since.
- MetLife Investment Management's Genpact position peaked at $5.1M in Q4 2022.
- 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.